Rupert Bartsch (R Bartsch)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Sentinel Lymph Node

Brain Metastases

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, Maximilian Marhold, Elisabeth Sophie Bergen, Sophie Roider-Schur, Maximilian Johannes Mair, Angelika Martina Starzer, Heidrun Forstner, Beate Rottenmanner, Marie-Bernadette Aretin, Karin Dieckmann, Zsuzsanna Bago-Horvath, Helmuth Haslacher, Georg Widhalm, Aysegül Ilhan-Mutlu, Christoph Minichsdorfer, Thorsten Fuereder, Thomas Szekeres, Leopold Oehler, Birgit Gruenberger, Georg Pfeiler, Christian Singer, Ansgar Weltermann, Luzia Berchtold, Matthias Preusser
FINAL outcome ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-positive breast cancer PATIENTS WITH active brain metastases. Neuro-oncology (2024)
Erwin Tomasich, Ariane Steindl, Christina Paiato, Teresa Hatziioannou, Markus Kleinberger, Luzia Berchtold, Rainer Puhr, Johannes A Hainfellner, Leonhard Müllauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna Sophie Berghoff
Frequent overexpression of HER3 in brain metastases from breast and lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Bolivar Arboleda-Osorio, Rupert Bartsch, Evandro de Azambuja, Erika Paige Hamilton, Nadia Harbeck, Jennifer R Klemp, Michael Knauer, Sherko Kuemmel, Reshma L Mahtani, Florian Scotté, Cynthia Villarreal Garza, Antonio Wolff
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel. The oncologist 27 (9) (2022)
Rupert Bartsch
ESMO 2020: highlights in breast cancer. Memo (2021)
Rupert Bartsch
ASCO 2020: highlights in breast cancer. Memo (2021)
Rupert Bartsch
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer. Memo (2021)
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe, null null
Circumnavigating the challenges of COVID-19 in oncology. Memo (2020)
Barbara Kiesewetter, Mircea Dediu, Rupert Bartsch
ESMO 2017-my personal highlights. Memo 11 (1) (2018)
Rupert Bartsch, Elisabeth Bergen
ASCO 2018: highlights in HER2-positive metastatic breast cancer. Memo 11 (4) (2018)
Rupert Bartsch, Elisabeth Bergen, Arik Galid
Current concepts and future directions in neoadjuvant chemotherapy of breast cancer. Memo 11 (3) (2018)
Rupert Bartsch, Elisabeth Bergen
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy. Memo 11 (3) (2018)
M Dediu, A Gerger, N Zojer, Rupert Bartsch
My personal highlights of ESMO 2016. Memo 10 (1) (2017)
Rupert Bartsch, Elisabeth Bergen
ASCO 2017: highlights in breast cancer. Memo 10 (4) (2017)
Rupert Bartsch, Elisabeth Bergen
ASCO 2016: highlights in breast cancer. Memo 9 (4) (2016)